Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07082244

Implant Phenotype Modification Via GBR and ADM

Phenotype Modification Via Guided Bone Regeneration and Acellular Dermal Matrix Simultaneous to Delayed Implant Placement: A Double Arm Randomized Controlled Clinical Trial.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Michigan · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Single implant sites with bone loss can often be managed by bone grafting alone. The purpose of this study is to determine whether putting a soft tissue graft substitute over the bone graft will provide an increased benefit for improving the health, appearance, and stability of the bone and gums surrounding the implant.

Detailed description

The study will treat patients that need a single implant at a previously edentulous site (\>3 months post extraction) that requires phenotypic modification. These patients will receive an implant with simultaneous GBR, with half of the participants also receiving an ADM graft.

Conditions

Interventions

TypeNameDescription
PROCEDUREDental implant placementParticipants will have a dental implant placed at a toothless site
PROCEDUREGuided bone regeneration with collagen membraneParticipants will receive guided bone regeneration at a toothless site with bone substitute and a collagen membrane.
PROCEDUREGuided bone regeneration with acellular dermal matrix.Participants will receive guided bone regeneration at a toothless site with bone substitute and an acellular dermal matrix.

Timeline

Start date
2025-06-01
Primary completion
2026-07-01
Completion
2026-09-01
First posted
2025-07-24
Last updated
2025-08-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07082244. Inclusion in this directory is not an endorsement.